🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-09-03
Trial ID
NCT01816594
Treatments Being Tested
The purpose of the trial is to determine the maximum tolerated dose (MTD) o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01285466
This phase II trial studies the effects of paclitaxel combined with phospho...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT01953445
Treatments Being Tested
Phase II Study of efficacy and safety of buparlisib (BKM120) plus paclitaxe...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2013-10-01
Trial ID
NCT01852292
Treatments Being Tested
The purpose of the first part of this study or the dose escalation portion ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02117817
Treatments Being Tested
The purpose of this study is to find out the good and bad effects that occu...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-02-15
Trial ID
NCT01297452
This study evaluated whether the addition of daily BKM120 to weekly paclita...
Status
Completed
Location
Ironwood Cancer and Research Centers SC
Start Date
2012-08
Trial ID
NCT01572727
Treatments Being Tested
The BURAN study is a randomized, open-label phase III study to assess the t...
Status
Completed
Location
City of Hope
Start Date
2020-12-12
Trial ID
NCT04338399
Treatments Being Tested
The Phase Ib part of the study aimed to determine the maximum tolerated dos...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2013-09-09
Trial ID
NCT01820325
Treatments Being Tested